Jason A. Jarzembowski, MD, PhD

Sr Associate Dean, Interim CEO CSG, Professor and Vice Chair, Pediatric Pathology, Medical Director CW Clinical Laboratory

Locations

Children's Wisconsin

Biography

Dr. Jarzembowski serves as Professor at the Medical College of Wisconsin and Staff Pathologist at Children's Wisconsin. He supervises a research program studying molecular abnormalities of the pediatric tumor neuroblastoma for which he was awarded the Young Investigator Research Award by the Society for Pediatric Pathology in 2005. He serves on the Editorial Boards of the Journal Archives of Pathology and Laboratory Medicine and Clinical Medicine; Pathology and is a Fellow of the College of American Pathologists and the American Society for Clinical Pathology. He is also an active member of the United States and Canadian Academy of Pathology, the Society for Pediatric Pathology and Sigma Xi.

View Provider Profile

Clinical Expertise

Autopsy
Fetal & Perinatal Pathology
Neuroblastoma
Pathology, Surgical
Placenta

Leadership Positions

Chair, Pathology Discipline Committee, Children's Oncology Group
Chief Executive Officer, Children's Specialty Group
Director. CRI Research Core Laboratories
Division Director, Pediatric Pathology, MCW Department of Pathology
Medical Advisor, Infant Death Center of Wisconsin
Medical Director, Pathology and Laboratory Medicine, Children's Hospital of Wisconsin
Program Director, Perinatal Pathology
Senior Associate Dean, Clinical Affairs (Pediatric), MCW

Pyrites: A Rectal Mass.

(Lyvannak S, Sereyleak B, Kakazu M, Bisiphan H, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Nov 01;46(8):446-447 PMID: 39028189 SCOPUS ID: 2-s2.0-85199520896 07/19/2024
Pyrites: A Cervical Mass.

(Lyvannak S, Sereyleak B, Keller FG, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Oct 01;46(7):390-391 PMID: 39028182 SCOPUS ID: 2-s2.0-85199515283 07/19/2024
Pyrites: Leukocytosis.

(Phauk C, Nhip A, Lyvannak S, Sereyleak B, Keller FG, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Oct 01;46(7):388-389 PMID: 38940591 SCOPUS ID: 2-s2.0-85205083253 06/28/2024
Pyrites: An Inguinal Mass.

(Lyvannak S, Sereyleak B, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Aug 01;46(6):333-334 PMID: 38934635 SCOPUS ID: 2-s2.0-85199815916 06/27/2024
Pyrites: A Supra-orbital Mass.

(Lyvannak S, Sereyleak B, Khauv P, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2024 Jul 01;46(5):279-280 PMID: 38912834 SCOPUS ID: 2-s2.0-85196944607 06/24/2024
Cellular Senescence Contributes to the Progression of Hyperoxic Bronchopulmonary Dysplasia.

(Jing X, Jia S, Teng M, Day BW, Afolayan AJ, Jarzembowski JA, Lin CW, Hessner MJ, Pritchard KA Jr, Naylor S, Konduri GG, Teng RJ.) Am J Respir Cell Mol Biol. 2024 Feb;70(2):94-109 PMID: 37874230 SCOPUS ID: 2-s2.0-85184825553 10/24/2023
Pyrites: A Conjunctival Mass.

(Lyvannak S, Sereyleak B, Khauv P, Mandziuk J, Jarzembowski J, Camitta B.) J Pediatr Hematol Oncol. 2023 Nov 01;45(8):e1039-e1040 PMID: 37027329 SCOPUS ID: 2-s2.0-85175357977 04/08/2023
Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics.

(Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, Ng CCY, Liu W, Lee JY, Lim AH, Guan P, Teh BT, Tan PH.) Histopathology. 2023 Sep;83(3):357-365 PMID: 37140543 SCOPUS ID: 2-s2.0-85156108581 05/04/2023
Pyrites: A Neck Mass.

(Lyvannak S, Sereyleak B, Jarzembowski J, Mandziuk J, Camitta B.) J Pediatr Hematol Oncol. 2023 May 01;45(4):223-224 PMID: 37027335 SCOPUS ID: 2-s2.0-85153414790 04/08/2023
Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics

(Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, Ng CCY, Liu W, Lee JY, Lim AH, Guan P, Teh BT, Tan PH.) Histopathology. September 2023;83(3):357-365 SCOPUS ID: 2-s2.0-85156108581 09/01/2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.

(Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, Pisapia D, Krasnozhen-Ratush O, Rosenblum M, Shroff S, Boué DR, Davidson C, Mao Q, Suchi M, North P, Hopp A, Segura A, Jarzembowski JA, Parsons L, Johnson MD, Mobley B, Samore W, McGuone D, Gopal PP, Canoll PD, Horbinski C, Fullmer JM, Farooqui MS, Gokden M, Wadhwani NR, Richardson TE, Umphlett M, Tsankova NM, DeWitt JC, Sen C, Placantonakis DG, Pacione D, Wisoff JH, Teresa Hidalgo E, Harter D, William CM, Cordova C, Kurz SC, Barbaro M, Orringer DA, Karajannis MA, Sulman EP, Gardner SL, Zagzag D, Tsirigos A, Allen JC, Golfinos JG, Snuderl M.) Neurooncol Adv. 2023;5(1):vdad076 PMID: 37476329 PMCID: PMC10355794 07/21/2023
Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeqTMKids for molecular profiling of childhood malignancies.

(Schilter KF, Smith BA, Nie Q, Stoll K, Felix JC, Jarzembowski JA, Reddi HV.) Front Genet. 2023;14:1067457 PMID: 36845394 PMCID: PMC9947346 02/28/2023